ClinicalTrials.govpublic full text
Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization
corneal neovascularization, bevacizumab (avastin), immunologic rejection, vascular endothelial growth factor, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979552
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.